Phase I/IB trial of eribulin and everolimus in patients with triple-negative metastatic breast cancer.

被引：1
|
作者：
Luu, Thehang H. [1 ]
Blanchard, Suzette [1 ]
Yim, John Hosei [1 ]
机构：
[1] City Hope Canc Ctr, Beckman Res Inst, Duarte, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.tps2637
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS2637
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase I clinical trial of the combination of eribulin and everolimus in patients with metastatic triple-negative breast cancer
    Lee, Jin Sun
    Yost, Susan E.
    Blanchard, Suzette
    Schmolze, Daniel
    Yin, Hongwei Holly
    Pillai, Raju
    Robinson, Kim
    Tang, Aileen
    Martinez, Norma
    Portnow, Jana
    Wen, Wei
    Yim, John H.
    Brauer, Heather Ann
    Ren, Yuqi
    Luu, Thehang
    Mortimer, Joanne
    Yuan, Yuan
    BREAST CANCER RESEARCH, 2019, 21 (01)
  • [2] Phase I clinical trial of the combination of eribulin and everolimus in patients with metastatic triple-negative breast cancer
    Jin Sun Lee
    Susan E. Yost
    Suzette Blanchard
    Daniel Schmolze
    Hongwei Holly Yin
    Raju Pillai
    Kim Robinson
    Aileen Tang
    Norma Martinez
    Jana Portnow
    Wei Wen
    John H. Yim
    Heather Ann Brauer
    Yuqi Ren
    Thehang Luu
    Joanne Mortimer
    Yuan Yuan
    Breast Cancer Research, 21
  • [3] Phase I trial of eribulin and everolimus in patients with metastatic triple negative breast cancer
    Yuan, Y.
    Yost, S.
    Blanchard, S.
    Yin, H.
    Li, M.
    Robinson, K.
    Tang, A.
    Martinez, N.
    Leong, L.
    Somlo, G.
    Patel, N. Tank
    Waisman, J.
    Portnow, J.
    Hurria, A.
    Luu, T-H
    Mortimer, J.
    CANCER RESEARCH, 2019, 79 (04)
  • [4] A phase Ib trial of bintrafusp alfa and eribulin in patients with metastatic triple negative breast cancer (TNBC)
    Damodaran, Senthil
    Liu, Diane
    Schwartz, Jill
    Valero, Vicente
    Ramirez, David
    Saleem, Sadia
    Ueno, Naoto T.
    Ibrahim, Nuhad K.
    Karuturi, Meghan S.
    Murthy, Rashmi K.
    Moulder, Stacy
    Litton, Jennifer K.
    CANCER RESEARCH, 2023, 83 (05)
  • [5] Phase Ib trial of olinvacimab and pembrolizumab in patients with metastatic triple-negative breast cancer
    Chan, Arlene
    Moylan, Eugene
    Jackson, Sally
    Devoto, Jeannette
    Jones, Nicola
    Radmil, Silvie
    Wilkinson, Kate
    Roohullah, Aflah
    Adam, Tamiem
    Lee, Seon Young
    Lee, Weon Sup
    Yoo, Jin-San
    CANCER RESEARCH, 2021, 81 (04)
  • [6] Eribulin Plus Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase Ib/II Study
    Tolaney, Sara M.
    Kalinsky, Kevin
    Kaklamani, Virginia G.
    D'Adamo, David R.
    Aktan, Gursel
    Tsai, Michaela L.
    O'Regan, Ruth M.
    Kaufman, Peter A.
    Wilks, Sharon T.
    Andreopoulou, Eleni
    Patt, Debra A.
    Yuan, Yuan
    Wang, Grace
    Savulsky, Claudio
    Xing, Dongyuan
    Kleynerman, Ella
    Karantza, Vassiliki
    Diab, Sami
    CLINICAL CANCER RESEARCH, 2021, 27 (11) : 3061 - 3068
  • [7] Phase Ib study of selinexor and eribulin combination in advanced solid tumors and triple-negative breast cancer.
    Nelson, Blessie Elizabeth
    Saleem, Sadia
    Damodaran, Senthil
    Somaiah, Neeta
    Piha-Paul, Sarina Anne
    Moore, Julia Ann
    Yilmaz, Bulent
    Karp, Daniel D.
    Dumbrava, Ecaterina Elena
    Tsimberidou, Apostolia Maria
    Hong, David S.
    Ahnert, Jordi Rodon
    Booser, Daniel J.
    Ibrahim, Nuhad K.
    Conley, Anthony Paul
    Bhosale, Priya
    Hernandez, Cristhiam Mauricio Rojas
    Tripathy, Debu
    Naing, Aung
    Meric-Bernstam, Funda
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [8] Neoadjuvant phase II trial with eribulin and carboplatin in patients with triple-negative breast cancer
    Giordano, Sara Barnato
    Rao, Shreyas
    Hamdan, Randala
    Jeruss, Jacqueline
    Bethke, Kevin
    Hansen, Nora
    Khan, Seema
    Von Roenn, Jamie
    Rosen, Steven
    Gradishar, William J.
    Siziopikou, Kalliopi
    Meservey, Caitlin
    Kaklamani, Virginia
    MOLECULAR CANCER RESEARCH, 2013, 11
  • [9] Phase I/II clinical trial of everolimus combined with gemcitabine/cisplatin for metastatic triple-negative breast cancer
    Park, In Hae
    Kong, Sun-Young
    Kwon, Youngmee
    Kim, Min Kyeong
    Sim, Sung Hoon
    Joo, Jungnam
    Lee, Keun Seok
    JOURNAL OF CANCER, 2018, 9 (07): : 1145 - 1151
  • [10] A phase I/II trial evaluating the safety and efficacy of eribulin in combination with copanlisib in patients with metastatic triple-negative breast cancer (TNBC)
    Bagegni, Nusayba Ali
    Nehring, Leslie
    Anderson, Jill
    Haas, Brittney
    Luo, Jingqin
    Trivedi, Meghna S.
    Kennedy, Laura Carpin
    Bhave, Manali A.
    Daily, Karen Colleen
    Razaq, Wajeeha
    Lu, Yiling
    Wang, Wei-Lien
    Wulf, Gerburg M.
    Said, Rabih
    Ma, Cynthia X.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345